Market Cap
Company ProfileJiangSu WuZhong Pharmaceutical Development Co. Ltd Market Cap History
Market Cap: CN¥206.2 Million
CNY as of Dec 1, 2025 | US$29.4 Million
Company Profile $600200JiangSu WuZhong Pharmaceutical Development Co. Ltd Market Capitalization Over Time
Evolution of JiangSu WuZhong Pharmaceutical Development Co. Ltd market cap history
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $209.25 B |
| Vertex Pharmaceuticals | $121.09 B |
| Regeneron Pharmaceuticals | $78.52 B |
| argenx | $52.93 B |
| Beigene Ltd. | $51.33 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
| Lilly | $1.024 T |
| Johnson & Johnson | $617.78 B |
| AbbVie | $443.36 B |
| Roche | $418.93 B |
| UnitedHealth Group | $376.34 B |
Yearly Market Cap Evolution
| Date | Market Cap | YoY Change |
|---|---|---|
| Jan. 1, 2025 | CN¥6.32 B | -3.61% |
| Jan. 1, 2024 | CN¥6.55 B | 15.57% |
| Jan. 1, 2023 | CN¥5.67 B | 15.19% |
| Jan. 1, 2022 | CN¥4.92 B | 50.33% |
| Jan. 1, 2021 | CN¥3.27 B | -38.81% |
| Jan. 1, 2020 | CN¥5.35 B | 30.44% |
| Jan. 1, 2019 | CN¥4.10 B | -49.78% |
| Jan. 1, 2018 | CN¥8.17 B | -34.93% |
| Jan. 1, 2017 | CN¥12.55 B | 31.18% |
| Jan. 1, 2015 | CN¥9.57 B | 28.96% |
| Jan. 1, 2014 | CN¥7.42 B | 29.37% |
| Jan. 1, 2013 | CN¥5.74 B |
Market capitalization is calculated from the opening stock price at the beginning of each year.
Stocks & Indexes
JiangSu WuZhong Pharmaceutical Development Co. Ltd main stocks and indexes inclusions.
$600200What is Market Capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.